CORONA Remedies Q2 FY26: Revenue Up 15.1% to ₹361 Cr, PAT Grows 21.8% to ₹52 Cr
CORONA Remedies Limited announced its unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2025. The company reported a consolidated revenue...
Limitations of AI summaries
AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.
Platforms like Prysm provide stock-level and portfolio-level analysis.
Why is CORONA Remedies Limited in the news today?
CORONA Remedies Limited (CORONA) is in the news due to the company reported significant year-on-year growth in both revenue and profit after tax for the quarter and half-year ended september 30, 2025, along with healthy return ratios, indicating a positive financial performance.
AI-Powered Summary
Market Context
Top Queries
More News
Explore Prysm Tools
Related Stories
CORONA Remedies Q2 FY26: Revenue Up 15.1% to ₹361 Cr, PAT Grows 21.8% to ₹52 Cr
January 2, 2026, 03:43 PM
Top Queries to Ask About CORONA Remedies Limited
More Details on This News
CORONA Remedies Limited announced its unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2025. The company reported a consolidated revenue from operations of ₹361.13 crore for Q2 FY26, marking a 15.1% year-on-year growth. For the half-year ended September 30, 2025 (H1 FY26), revenue stood at ₹707.67 crore, up 17.0% year-on-year.
Profit After Tax (PAT) for Q2 FY26 was ₹52.32 crore, an increase of 21.8% year-on-year. H1 FY26 PAT reached ₹98.52 crore, showing a significant growth of 35.1% year-on-year. The company also highlighted healthy return ratios, with RoE at 31.1% (annualized) and RoCE at 49.7% for H1 FY26.
Commenting on the results, Mr. Nirav K. Mehta, Managing Director and CEO, stated that the strong performance reflects the company's consistent strategy, disciplined execution, and focus on core therapeutic segments. He also expressed gratitude to bankers for the successful listing on Indian stock exchanges.
The company will conduct an earnings call on January 05, 2026, at 12:00 PM IST to discuss the financial and business performance.
See What Deep Dive Gives You — in Seconds
“what happens when you click
Deep Dive “
“what happens when you click Deep Dive “
Instant AI Summary - “Get clean, noise-free earnings breakdowns.”
PDF Insights - “Download detailed, AI-generated reports.”
Metrics Explained -“Key ratios & trends explained in simple language.”
Want to know if this news pushes your stock up or down?
Just tap
